EE3-22340-18010
5 vaccinations
5 coded responses
39 check-ins
5 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 945 / CA
- Registered
- 2021-02-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-02-03
Registered in v-safe
-
2021-02-03
Dose 1 — Pfizer-BioNTech
- 2021-02-03
- 2021-02-04
-
2021-02-05
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-02-06
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-07
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fever · Muscle or body achesAdult check-in
-
2021-02-08
Health check-in — days 1–6 daily, dose 1Feeling: Good · Joint pains, Muscle or body achesAdult check-in
- 2021-02-09
- 2021-02-10
- 2021-02-17
- 2021-02-24
-
2021-03-04
Dose 2 — Pfizer-BioNTech
- 2021-03-04
-
2021-03-09
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-11
Health check-in — day 7, dose 2Feeling: Good · Headache, Joint pains, Muscle or body achesAdult check-in
-
2021-03-18
Survey response — day 14, dose 2MedDRA: Injection site pain, Peripheral swelling, Vasodilatation — Feeling: GoodFree text: Shoulder shot arm left pain and left lower leg swelling with bulging veins.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-25
Survey response — day 21, dose 2MedDRA: Arthralgia — Feeling: GoodFree text: Sore left shoulder where shot administered.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-01
- 2021-04-08
-
2021-04-15
Survey response — day 42, dose 2MedDRA: Arthralgia, Respiratory tract congestion, Somnolence — Feeling: FairFree text: Sleepy, head feels stuffy, and continued hand arthritics/pain.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-03
- 2021-09-02
-
2021-10-09
Dose 3 — Pfizer-BioNTech
- 2022-03-04
- 2022-04-09
-
2022-04-15
Dose 4 — Pfizer-BioNTech
- 2022-04-20
- 2022-04-21
- 2022-04-22
- 2022-04-29
- 2022-05-06
-
2022-05-20
Survey response — day 35, dose 4MedDRA: Abdominal pain upper, Diarrhoea, Dysgeusia, Muscle spasms, Oropharyngeal pain, SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVID-19 positive test on Wednesday 2022-05-18 symptoms: Diarrhea, sore throat, bitter taste in mouth, cramping and stomachacheMedDRA releases: 2024-11 · check-in free text available
-
2022-05-27
Survey response — day 42, dose 4MedDRA: Anxiety, Body temperature increased, Faeces soft, Headache — Feeling: FairFree text: Soft stool, anxiety, occasional headaches, elevated temperature 99.0 but quickly back to 97.5 F.MedDRA releases: 2024-11 · check-in free text available
- 2022-07-15
-
2022-10-05
Dose 5 — Pfizer-BioNTech
- 2022-10-14
- 2022-10-19
- 2022-10-28
- 2022-11-02
- 2022-11-09
- 2022-11-16
- 2023-01-04
- 2023-04-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-03 | Pfizer-BioNTech | |
| 2 | 2021-03-04 | Pfizer-BioNTech | |
| 3 | 2021-10-09 | Pfizer-BioNTech | No |
| 4 | 2022-04-15 | Pfizer-BioNTech | No |
| 5 | 2022-10-05 | Pfizer-BioNTech | No |
Free text
Release 5 — day 14, dose 2
Symptoms: Shoulder shot arm left pain and left lower leg swelling with bulging veins.
Release 6 — day 21, dose 2
Symptoms: Sore left shoulder where shot administered.
Release 7 — day 42, dose 2
Symptoms: Sleepy, head feels stuffy, and continued hand arthritics/pain.
Release 11 — day 35, dose 4
Symptoms: COVID-19 positive test on Wednesday 2022-05-18 symptoms: Diarrhea, sore throat, bitter taste in mouth, cramping and stomachache
Release 11 — day 42, dose 4
Symptoms: Soft stool, anxiety, occasional headaches, elevated temperature 99.0 but quickly back to 97.5 F.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain upper | · | · | ✓ |
| SD | Anxiety | · | · | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Body temperature increased | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Dysgeusia | · | · | ✓ |
| SD | Faeces soft | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Muscle spasms | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Peripheral swelling | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Somnolence | ✓ | ✓ | ✓ |
| SD | Vasodilatation | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release